This inventor holds 1 USPTO granted patent. Top assignees: Mahidol University, Osaka University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 9 
1 out of 1,045 
Years Active: 2023
Title: Aekkachai Tuekprakhon: Innovator in Monoclonal Antibodies
Introduction
Aekkachai Tuekprakhon is a notable inventor based in Bangkok, Thailand. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on combating viral infections, showcasing his commitment to advancing medical science.
Latest Patents
Aekkachai Tuekprakhon holds a patent for "Broad-spectrum monoclonal antibodies against chikungunya virus E1 structural protein." This invention provides a new antibody targeting various types of Chikungunya virus, including ECSA, WA, and Asian types. The antibody comprises a heavy chain variable region and a light chain variable region, which are crucial for its functionality.
Career Highlights
Throughout his career, Aekkachai has worked with prestigious institutions such as Osaka University and Mahidol University. His research has contributed to the understanding and treatment of viral diseases, particularly those caused by the Chikungunya virus.
Collaborations
Aekkachai has collaborated with esteemed colleagues, including Tatsuo Shioda and Emi Nakayama. These partnerships have enhanced his research efforts and expanded the impact of his work in the scientific community.
Conclusion
Aekkachai Tuekprakhon is a pioneering inventor whose work in monoclonal antibodies represents a significant advancement in the fight against viral infections. His contributions continue to influence the field of biotechnology and improve public health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile